Escherichia coli and TNF-α Modulate Macrophage Phagocytosis of Candida glabrata1

Journal of Surgical Research

Volumn 155, Issue 2, 2009, Pages 217-224

  Hess, Donavon J ^a   Henry Stanley, Michelle J ^a   Bendel, Catherine M ^a   Zhang, Bin ^a   Johnson, Mary Alice ^a   Wells, Carol L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Candida glabrata; Escherichia coli; lipopolysaccharide; macrophage; tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; CANDIDA GLABRATA; CANDIDIASIS; CELL CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; EX VIVO STUDY; HEPATITIS; HOST RESISTANCE; KIDNEY INFECTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CANDIDA GLABRATA; CANDIDIASIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES, PERITONEAL; MICE; PHAGOCYTOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650945161     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.022     Document Type: Article

References (33)

1. Rangel-Frausto M., Wiblin T., Blumberg H.M., et al. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29 (1999) 253
2. Pappas P.G., Rex J.H., Lee J., et al. A perspective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37 (2003) 634
3. Charles P.E., Doise J.M., Quenot J.P., et al. Candidemia in critically ill patients: Difference of outcome between medical and surgical patients. Intensive Care Med 29 (2003) 2162
4. Peres-Bota D., Rodriguez-Villalobos H., Dimopoulos G., et al. Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 10 (2004) 550
5. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial blood stream infections in U.S. hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309
6. Snydman D.R. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 123 (2003) 500S
7. Gudlaugsson O., Gillespie S., Lee K., et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37 (2003) 1172
8. Lipsett P.A. Surgical critical care: Fungal infections in surgical patients. Crit Care Med (2006) S215
9. Csank C., and Haynes K. Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett 189 (2000) 115
10. Fidel Jr. P.L., Vazquez J.A., and Sobel J.D. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12 (1999) 80
11. Brieland J., Essig D., Jackson C., et al. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun 69 (2001) 5046
12. Blot S., Vandewoude K., Hoste E., et al. Outcomes in critically ill patients with candidal fungemia: Candida albicans versus Candida glabrata. J Hosp Infect 47 (2001) 308
13. Hederwick S.A., Lyons M.J., Liu M., et al. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 19 (2000) 663
14. Burd R.S., Raymond C.S., and Dunn D.L. Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. J Surg Res 52 (1992) 537
15. Klaerner H.G., Uknis M.E., Acton R.D., et al. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. J Surg Res 70 (1997) 161
16. Akagawa G., Abe S., and Yamaguchi H. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J Infect Dis 171 (1995) 1539
17. Goetz F.W., Planas J.V., and MacKenzie S. Tumor necrosis factors. Dev Comp Immunol 28 (2004) 487
18. Spellberg B., Ibrahim A.S., Edwards Jr. J.E., et al. Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 192 (2005) 336
19. Bendel C.M., Hess D.J., Garni R.M., et al. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med 31 (2003) 501
20. In: Winn W., Allen S., and Janda W. (Eds). Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6th ed. (2006), Williams and Wilkins, Philadelphia: Lippincott
21. Odds F.C., and Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32 (1994) 1923
22. Remick D.G., Newcomb D.E., Bolgos G.L., et al. Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide versus cecal ligation and puncture. Shock 13 (2000) 110
23. Sundgren-Anderson A., Ostlund P., and Bartfai T. IL-6 is essential in TNF-α induced fever. Am J Physiol 275 (1998) R2028
24. van der Laan L.J.W., Dopp E.A., Haworth R., et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 162 (1999) 939
25. Bopp L.H., Baltch A.L., Ritz W.J., et al. Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei, and Candida parapsilosis in human monocyte-derived macrophages. J Med Microbiol 55 (2006) 865
26. Baltch A.L., Bopp L.H., Smith R.P., et al. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon-γ on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages. Diagnot Microbiol Infect Dis 52 (2005) 299
27. Garcha U.K., Brummer E., and Stevens D.A. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J Infect Dis 172 (1995) 1620
28. van der Graff C.A.A., Netea M.G., Verschueren I., et al. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 73 (2005) 7458
29. Murray R.Z., Kay J.G., Sangermani D.G., et al. A role for the phagosome in cytokine secretion. Science 310 (2005) 1492
30. Steinshamn S., and Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 60 (1992) 4003
31. Kielian T.L., and Blecha F. CD14 and other recognition molecules for lipopolysaccharide: A review. Immunopharmacology 29 (1995) 187
32. Vonk A.G., Netea M.G., van Krieken J.H., et al. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-α- and lymphotoxin-α-deficient mice. J Infect Dis 186 (2002) 1815
33. Louie A., Baltch A.L., Smith R.P., et al. Tumor necrosis factor-α has a protective role in a murine model of systemic candidiasis. Infect Immun 62 (1994) 2761